Filing Flows › Connect Biopharma Holdings (CNTB) › Recalls, complaints & regulation

Connect Biopharma Holdings (CNTB): clinical trials

Connect Biopharma Holdings (CNTB) beyond its filings: 1 active clinical trial.

Connect Biopharma Holdings' latest quarter

Connect Biopharma Holdings, Q2 2026: revenue $2.8M (58× year over year), operating margin -636.0%, net loss $17.3M, operating cash flow −$15.9M. The chart follows the revenue to costs, profit and cash.

Questions

How many clinical trials does Connect Biopharma Holdings have?

1 active study on ClinicalTrials.gov, 0 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.